Fibrinogen Antikörper (HRP)
Kurzübersicht für Fibrinogen Antikörper (HRP) (ABIN568521)
Target
Alle Fibrinogen Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Molar Ratio: Peroxidase/IgG ~1.7
-
Aufreinigung
- Hyperimmune antisera with strong precipitating activity are selected for fractionation by saltprecipitation and purification of the IgG fraction by DEAE-chromatography.
-
Immunogen
- Fibrinogen is isolated from fresh plasma after removing Prothrombin. Freund’s complete adjuvant is used in the first step of the immunization procedure
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Rekonstitution
- Restore by adding 1 mL of sterile distilled water.
-
Konzentration
- 10 mg/mL
-
Buffer
- PBS, pH 7.2 without preservatives.
-
Konservierungsmittel
- Without preservative
-
Handhabung
- Avoid Repeated thawing and freezing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store lyophilized at 2-8 °C and reconstituted at 2-8 °C for one week or (in aliquots) at -20 °C for longer.
-
-
- Fibrinogen
-
Hintergrund
- Fibrinogen (clotting factor I) is a heat labile beta glycoprotein present in plasma. It is the precursor of fibrin, which is the key protein constituting the network of the blood clot. Thrombin converts fibrinogen to fibrin by limited proteolysis, releasing the fibrinopeptides A and B (molecular weight 50,000-65,000) and forming fibrin monomers. Fibrin monomers polymerize to fibrin which is stabilized by cross-linking under the influence of factor XIII. The predominant gamma chain of normal fibrinogen (MW 50,000, with higher variants) has a low affinity for platelet binding.Synonyms: FGA, FGB, FGG
Target
-